ST TROPEZ, FRANCE, April 28, 2011 (Press-News.org) Are classic sailing yachts becoming more popular than their motor yacht rivals? Figures are suggesting that maybe owing to economic and environmental conditions people are making a move from motor to sail.
William Bishop, Head of YPI Sail explains, "Being at sea on a sailing yacht is an entirely different experience to being on a motor yacht. Sailing yachts allow you to enjoy the journey as much as the destination. There are few people not captivated by the beauty and grace of a sailing yacht gliding into anchorage at sail. They slice through the water so the only noise you hear is the wind and the sea and the sound of nature itself. For many, sailing is being a part of what is around you...not an observer."
Whether you're looking for the exhilaration that comes from taking a super yacht charter on a carbon 100' yacht or are keen to sail in complete comfort on a large J-Class whilst taking a crewed yacht charter around the Mediterranean, there are some great sailing vessels on the market at stunning prices in 2011.
With the world becoming increasingly more eco-minded coupled with the current economic climate, more customers are leaning towards sailing vessels as opposed to fuel hungry motor yachts.
"Sailing yachts tend to be more economical to run than motor yachts," explains Mr Bishop. "It doesn't matter how much money you are worth, money saved on fuel is money that can be enjoyed elsewhere. They are also environmentally responsible. They use wind power, they recycle and store energy. ETHEREAL, for example, uses a hybrid electric-diesel propulsion system and lithium batteries that charge when the yacht is under sail. And these innovations come without any need for compromise on the luxury of the experience onboard."
Gone are the days of cramped quarters and hard manual rope work! Yachts such as the WINDROSE and VANQUEST offer sumptuous living conditions and considerable space for those onboard. Most come with state of the art entertainment and communication equipment and with extra quarters for an onboard crew your time is better spent enjoying yourself on your very own crewed yacht charter.
"All sail yachts have engines so they don't have to rely on the wind," explains Will. "Most sailing yachts can motor up to speeds of 10 knots. There also exists a hybrid between sail and motor yachts. Motorsailers give owners and guests the freedom to cruise the yacht either under sail or under power at even greater speeds, as well as offering more deck space than traditional sail yachts and increased storage for water sports equipment." Explains Head of YPI Charter, Fiona Maureso
Widely respected as one of the industries foremost yacht charter brokers, YPI Group have a large portfolio of luxury sailing yachts available for a crewed yacht charter or sale. YPI Group are proud to have some of the finest examples of sailing yachts on their books available for sale or super yacht charter.
LIONHEART - One of the finest and largest J-Class to date the LIONHEART was nominated by the World Superyacht Awards' panel.
METEOR - This multi-award winning schooner has a reputation for being one of the best appointed sailing yachts on the market today.
WINDROSE - A yacht that evokes memories of a bygone era the WINDROSE was conceived to win races and offers stunning performances under sail.
Yachting Partners International (YPI Group) is a yacht charter broker and yacht sales broker and is part of the Barry Rogliano Salles Shipbroking Group (BRS). Renowned for its integrity, considerable industry experience and for getting results this yacht management company has accumulated vast experience in the fields of luxury yacht design, yacht refitting, yacht crew placement, crewed yacht charter, super yacht charter and super yacht sales for some of the most discerning clients all over the world as well as an in-house crew agency. For further details regarding any of the above sailing yachts, or for a more general enquiry please visit us at website.
Website: http://www.ypigroup.com
YPI Group Yachting Exclusive - Sail Power Proves More Popular Than Horse Power
2010 saw sailing yacht sales almost double 2009's figures say yachting brokers YPI Group.
2011-04-28
ELSE PRESS RELEASES FROM THIS DATE:
Record number of whales, krill found in Antarctic bays
2011-04-28
DURHAM, N.C. – Scientists have observed a "super-aggregation" of more than 300 humpback whales gorging on the largest swarm of Antarctic krill seen in more than 20 years in bays along the Western Antarctic Peninsula.
The sightings, made in waters still largely ice-free deep into austral autumn, suggest the previously little-studied bays are important late-season foraging grounds for the endangered whales. But they also highlight how rapid climate change is affecting the region.
The Duke University-led team tracked the super-aggregation of krill and whales during a six-week ...
Rice University geologist leads team effort to solve mystery of the Colorado Plateau
2011-04-28
A team of scientists led by Rice University has figured out why the Colorado Plateau – a 130,000-square-mile region that straddles Colorado, Utah, Arizona and New Mexico -- is rising even while parts of its lower crust appear to be falling. The massive, tectonically stable region of the western United States has long puzzled geologists.
A paper published today in the journal Nature shows how magmatic material from the depths slowly rises to invade the lithosphere -- Earth's crust and strong uppermost mantle. This movement forces layers to peel away and sink, said lead ...
Study: Resiniferatoxin may increase sepsis-related mortality
2011-04-28
Washington, DC — Pain researchers from the Sheikh Zayed Institute for Pediatric Surgical Innovation at
Children's National Medical Center have discovered that resiniferatoxin, a drug that has shown early promise as an option for chronic, severe pain sufferers, may decrease the body's ability to fight off bacterial infections, particularly sepsis.
The study, which appears in the May 1 edition of the journal Anesthesiology, sheds new light on the role of a pain receptor, transient receptor potential vanilloid-1 (TRPV1), and how medications designed to impact this receptor's ...
Brain regions can take short naps during wakefulness, leading to errors
2011-04-28
Madison, Wis. – If you've ever lost your keys or stuck the milk in the cupboard and the cereal in the refrigerator, you may have been the victim of a tired brain region that was taking a quick nap.
Researchers at the University of Wisconsin-Madison have a new explanation.
They've found that some nerve cells in a sleep-deprived yet awake brain can briefly go "off line," into a sleep-like state, while the rest of the brain appears awake.
"Even before you feel fatigued, there are signs in the brain that you should stop certain activities that may require alertness," says ...
Women at higher risk than men of kidney damage after heart imaging test
2011-04-28
DETROIT – Women are at higher risk than men of developing kidney damage after undergoing a coronary angiogram, according to a Henry Ford Hospital study.
Researchers found that women are 60 percent more likely than men to develop radiocontrast-induced nephropathy (RCIN), an adverse side effect that causes kidney dysfunction within 24 to 72 hours after patients are administered an iodine contrast dye during the common heart imaging test.
This is believed to be the first study in which researchers investigated whether gender played a role in patients developing RCIN after ...
Neurorobotics reveals brain mechanisms of self-consciousness
2011-04-28
A new study uses creative engineering to unravel brain mechanisms associated with one of the most fundamental subjective human feelings: self-consciousness. The research, published by Cell Press in the April 28 issue of the journal Neuron, identifies a brain region called the temporo-parietal junction (TPJ) as being critical for the feeling of being an entity localized at a particular position in space and for perceiving the world from this position and perspective.
Recent theories of self-consciousness highlight the importance of integrating many different sensory and ...
Scientists identify genetic risk for major depression
2011-04-28
A new study reveals a novel gene associated with major depression. The research, published by Cell Press in the April 28 issue of the journal Neuron, suggests a previously unrecognized mechanism for major depression and may guide future therapeutic strategies for this debilitating mood disorder.
Major depression is a psychiatric disorder that is responsible for a substantial loss in work productivity and can even lead to suicide in some individuals. "Current treatments for major depression are indispensible but their clinical efficacy is still unsatisfactory, as reflected ...
IPF lung disease numbers are rising quickly to become a significant cause of mortality in UK
2011-04-28
The number of cases of idiopathic pulmonary fibrosis (IPF) has continued to rise significantly in the first decade of the 21st century and could lead to more deaths than ovarian cancer, lymphoma, leukaemia, or kidney cancer, reveals research published ahead of print in the Thorax journal.
IPF is the most common of the pneumonias that happen without an apparent cause and previous studies have shown that incidence and deaths from the disease are rising in the UK and the USA.
However, there is currently no mandatory registration of IPF diagnoses in the UK or anywhere ...
New target structure for antidepressants on the horizon?
2011-04-28
They were able to show for the first time that physiologically measurable changes can be observed in the brains of healthy carriers of this risk allele. These changes affect a transporter protein involved in the production of an important neuronal transmitter. Given that traditional drugs interact with similar transporter molecules, the researchers are pinning great hopes on this factor as the target structure of future antidepressant medication.Scientists throughout the world have been trying to identify the genetic causes of depression for many years. The fact that a ...
New opioid-blocking medication effective to treat opioid dependence, in Lancet study
2011-04-28
WALTHAM, Mass., April 27, 2011 – Alkermes, Inc. (NASDAQ: ALKS) today announced that results from the phase 3 clinical study of VIVITROL® (naltrexone for extended-release injectable suspension) in opioid dependence have been published by The Lancet. The six-month, phase 3 trial met its primary endpoint and showed significantly greater opioid-free weeks among patients treated with VIVITROL, compared to placebo. VIVITROL is the first and only non-addictive, non-narcotic, once-monthly medication approved by the U.S. Food and Drug Administration (FDA) for the prevention of ...
LAST 30 PRESS RELEASES:
Science briefing: An update on GLP-1 drugs for obesity
Lower doses of immunotherapy for skin cancer give better results
Why didn’t the senior citizen cross the road? Slower crossings may help people with reduced mobility
ASH 2025: Study suggests that a virtual program focusing on diet and exercise can help reduce side effects of lymphoma treatment
A sound defense: Noisy pupae puff away potential predators
Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy
Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes
New findings support a chemo-free approach for treating Ph+ ALL
Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL
University of Cincinnati experts present research at annual hematology event
ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial
ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer
ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors
Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient
Continuous and fixed-duration treatments result in similar outcomes for CLL
Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia
Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease
Roughly one-third of families with children being treated for leukemia struggle to pay living expenses
Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy
IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection
Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients
Emergency departments fall short on delivering timely treatment for sickle cell pain
Study shows no clear evidence of harm from hydroxyurea use during pregnancy
Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease
Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia
Early results suggest exa-cel gene therapy works well in children
NTIDE: Disability employment holds steady after data hiatus
Social lives of viruses affect antiviral resistance
Dose of psilocybin, dash of rabies point to treatment for depression
Helping health care providers navigate social, political, and legal barriers to patient care
[Press-News.org] YPI Group Yachting Exclusive - Sail Power Proves More Popular Than Horse Power2010 saw sailing yacht sales almost double 2009's figures say yachting brokers YPI Group.




